According to Stoke Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.11 B. In 2022 the company made an earning of -$0.11 B a decrease over its 2021 earnings that were of -$85.81 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.11 B | 3.59% |
2022 | -$0.11 B | 17.79% |
2021 | -$85.81 M | 64.24% |
2020 | -$52.25 M | 61.62% |
2019 | -$32.33 M | 158.17% |
2018 | -$12.53 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | 5.81% | ๐บ๐ธ USA |